Angela Walsh
Senior Vice President of Finance and Treasurer
Replay available
Virios Therapeutics, Inc. (VIRI) Q2 2023 Earnings Call
Virios Therapeutics, Inc. (NASDAQ: VIRI) Q2 2023 earnings conference call, held 2023-08-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Shawn Lee
Analyst, HC Wainwright
Dr. Mike Gendro
Chief Medical Officer
Greg Duncan
Chief Executive Officer
David Bouts
Analyst, Zacks Small Cap Research
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Dogwood Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.029 -- 00:00:05.652 Angela Walsh, Senior Vice President of Finance and Treasurer of Vireos Therapeutics. 00:00:05.652 -- 00:00:08.292 Please proceed, Angela. 00:00:10.254 -- 00:00:14.696 Thank you. Good morning, everyone, and thank you for joining us on today's conference 00:00:14.696 -- 00:00:19.938 call. We are pleased to be with you today to discuss Vireos Therapeutics second quarter 00:00:19.938 -- 00:00:24.480 financial results and corporate update. Please note that our financial results press 00:00:24.480 -- 00:00:27.821 release is now available on our website. 00:00:27.821 -- 00:00:32.730 Before we begin, I'd like to remind everyone that statements made during this conference 00:00:32.730 -- 00:00:37.572 call will include forward-looking statements within the meaning of the Private Securities 00:00:37.572 -- 00:00:40.914 Litigation Reform Act of 1995, 00:00:40.914 -- 00:00:46.557 which involved risks and insurgencies that can cause actual results to differ materially 00:00:46.557 -- 00:00:51.440 from the information expressed or implied by these forward-looking statements. 00:00:51.440 -- 00:00:56.523 For more information regarding such risks and insurgencies, please see the risk factors 00:00:56.523 -- 00:01:00.447 outlined in the company's filings with the SEC. 00:01:00.447 -- 00:01:05.268 Any forward-looking statements are made only as of today, and we disclaim any obligation 00:01:05.268 -- 00:01:09.509 to update these forward-looking statements other than as required by law. 00:01:09.509 -- 00:01:14.109 Please see the forward-looking statements section in our financial results release issued 00:01:14.109 -- 00:01:16.490 this morning for more information. 00:01:16.490 -- 00:01:22.171 It is now my pleasure to turn the call over to our CEO, G...